Exact Mass: 408.2373
Exact Mass Matches: 408.2373
Found 500 metabolites which its exact mass value is equals to given mass value 408.2373
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
1-palmitoyl-dihydroxyacetone-phosphate
1-palmitoyl-dihydroxyacetone-phosphate is also known as Palmitoyl glycerone phosphate or Hexadecanoate 2-oxo-3-(phosphonooxy)propyl ester. 1-palmitoyl-dihydroxyacetone-phosphate is considered to be practically insoluble (in water) and acidic. 1-palmitoyl-dihydroxyacetone-phosphate is an other glycerophospholipid lipid molecule
Cascarillin
Cascarillin is a constituent of Croton eleuteria (cascarilla). Constituent of Croton eleuteria (cascarilla)
Heterophylol
Heterophylol is found in fruits. Heterophylol is a constituent of the root bark of Artocarpus heterophyllus (jackfruit). Constituent of the root bark of Artocarpus heterophyllus (jackfruit). Heterophylol is found in fruits.
cis-Methylbixin
cis-Methylbixin is a constituent of Bixa orellana (annatto). Constituent of Bixa orellana (annatto)
Anhydrocinnzeylanine
Anhydrocinnzeylanine is found in chinese cinnamon. Anhydrocinnzeylanine is isolated from Cinnamomum cassia (Chinese cinnamon). Isolated from Cinnamomum cassia (Chinese cinnamon). Anhydrocinnzeylanine is found in chinese cinnamon and herbs and spices.
trans-Methylbixin
trans-Methylbixin is a constituent of Bixa orellana (annatto). Constituent of Bixa orellana (annatto)
1-(9Z-hexadecenoyl)-glycero-3-phosphate
1-(9Z-hexadecenoyl)-glycero-3-phosphate is also known as LPA(16:1(9Z)/0:0). 1-(9Z-hexadecenoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(9Z-hexadecenoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
Lofentanilum
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
MG(PGJ2/0:0/0:0)
MG(PGJ2/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/PGJ2/0:0)
MG(0:0/PGJ2/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
[8]-Gingerdiol
[8]-gingerdiol is a member of the class of compounds known as fatty alcohol esters. Fatty alcohol esters are ester derivatives of a fatty alcohol. [8]-gingerdiol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). [8]-gingerdiol can be found in ginger, which makes [8]-gingerdiol a potential biomarker for the consumption of this food product.
(9Z,9'Z)-Methylbixin
Constituent of Bixa orellana (annatto).
Epiarguticinin
Tenuifolin A (isoflavan)
Arguticinin
cis-Methylbixin
cis-Methylbixin is a constituent of Bixa orellana (annatto). Constituent of Bixa orellana (annatto)
3alpha-angeloyloxy-4alpha-acetoxy-11-peroxy-eudesm-6-en-8-one|4-O-acetyl-11-hydroperoxy-6,7-dehydro-7,11-dihydrocuauthemone 3-O-angelate
3beta-angeloyloxy-6beta-ethoxy-8beta,10beta-dihydroxyeremophilenolide|3??-Angeloyloxy-6??-ethoxy-8??,10??-dihydroxyeremophilenolide
Nimbocinol
A tetracyclic triterpenoid that is 4,4,8-trimethylandrosta-1,14-diene substituted by a oxo groups at positions 3 and 16, a hydroxy group at position 7 and a furan-3-yl group at position 17. It has been isolated from Azadirachta indica.
18-Ac-7,8,16,18-Tetrahydroxy-19-serrulatanoic acid|18-acetoxy-7,8,16-trihydroxyserrulatan-19-oic acid
(rel 5S,6R,8R,9R,10S,13S,16S)-6-acetoxy-9,13-epoxy-16-methoxy-labdan-15,16-olide
1-[3-(2-dimethylaminoethyl)-5-hydroxy-1h-4-indolyl]-3-hydroxy-3-(2-methylaminoethyl)-2-indolinone
7alpha,11beta,14beta,18-tetrahydroxy-20-acetoxy-ent-kaur-16-en-15-one|isolushinin I
8alpha-(2-methylbutyroyloxy)-10beta-hydroxy-11alpha-acetoxyslov-3-enolide
8beta-acetoxy-3beta-isobutyryloxy-5alpha-hydroxycostic acid methyl ester
(7beta,11S,12S,13S,20S)-12,20-Epoxy-7,11,13,20-tetrahydroxy-3,14-clerodadien-2-one
(1alpha,6beta)-1,6-dihydroxytorilin|(3aR,4S,6R,7S,8R)-7-[1-(acetyloxy)-1-methylethyl]-2,3,3a,4,5,6,7,8-octahydro-3a,8-dihydroxy-1,4-dimethyl-2-oxoazulen-6-yl (2Z)-2-methylbut-2-enoate|(6beta,8beta)-8-(angeloyloxy)-11-(acetyloxy)-1,6-dihydroxyguai-4-en-3-one
(3S,5S,8R,9R,10S,13S,16S)-3-acetoxy-9,13-epoxy-16-methoxylabdan-15,16-olide|negundoin D
Australifungin
A carbobicyclic compound that is 4a,5,6,7,8,8a-hexahydronaphthalen-1(4H)-one substituted by hydroxy groups at positions 2, 5 and 8, a (2Z)-3-hydroxyprop-2-enoyl group at position 4, methyl groups at positions 4 and 7 and a 2R-octan-2-yl group at position 3 (the 4S,4aR,5S,7R,8R,8aS stereoisomer). It is isolated from the fermentation extracts of Sporormiella australis and exhibits antifungal activity by interfering with the fungal lipid metabolism.
(rel-5S,6R,8R,9R,10S)-6-acetoxy-9-hydroxy-16-methoxy-13(14)-labden-15,16-olide|viteagnusin H
2-(2-acetoxytridecyl)-6-hydroxy-4-methoxybenzoic acid
3beta,7alpha,12alpha,14beta-tetrahydroxy-19-acetoxy-ent-kaur-16-en-15-one|pharicinin E
12-Deoxy,2-Ac,4-Me ether-(2R,12S)-6-(2,12-Dihydroxytridecyl)-2,4-dihydroxybenzoic acid
3,3-dimethyl-1,2,3,4,5,6,1,2,3,4,5,6,9,10-tetradecahydro-[9,10]bi[1,5-methano-pyrido[1,2-a][1,5]diazocinyl]-8,8-dione|Dimethamin
(1alpha,11beta,15beta)-1-acetoxy-6,11,15-trihydroxy-6,7-seco-ent-kaur-16-eno-7(20)-lactone|(1S,2R,4aS,5S,6S,7S,9R,9aS)-6-acetoxy-hexahydro-5,9-dihydroxy-2-hydroxymethyl-3,3-dimethyl-8-methylenespiro[cyclohexane-1,4(3H)-[1H-7,9a]methanooxycyclohepta[c]pyran]-1-one|isojaponin B
4-hydroxy-5-methoxy-8,8-bis(3-methylbut-2-enyl)-2-phenyl-3,4-dihydro-2H-chromen-7(8H)-one|pongaflavanol
2,4-Dihydroxy-3,5-bis(3-methyl-2-butenyl)-6-phenethylbenzoic acid methyl ester
(3alpha,6beta,7alpha,14R,15beta)-7,20-epoxy-ent-kaur-16-ene-3,6,7,14,15-pentol 6-acetate|rabdonervosin D
methyl 6beta-hydroxy-18-acetoxy-grindelane methyl ester
(1S,4aR,6aR,7S,10aR,11aS,11bS)-1,2,3,4,4a,5,6,6a,7,9,10a,11,11a,11b-tetradecahydro-4a,7,10a-trihydroxy-4,4,7,11b-tetramethyl-9-oxophenanthro[3,2-b]furan-1-yl acetate|caesalpinolide F
(1S,4aR,6S,7R,10aR,11bS)-1,2,3,4,4a,5,6,6a,7,9,10a,11,11a,11b-tetradecahydro-4a,6,10a-trihydroxy-4,4,7,11b-tetramethyl-9-oxophenan-thro[3,2-b]furan-1-yl acetate|caesalpinolide G
1alpha,7alpha,14beta,15beta-tetrahydroxy-3-beta-acetoxy-ent-kaur-16-en-12-one|dihydropseurata F|pharicunin H
dimethyl (14S)-(2E,6E,10Z)-6-methoxycarbonyl-2,10,14-trimethylhexadeca-2,6,10-trienedioate
(2R)-6-(2-acetoxytridecyl)-5-formyl-2-methoxy-1,4-dihydroxybenzene
11beta-de-acetylternifolin|1alpha,7beta,11beta,15beta-tetrahydroxy-6beta-acetoxy-7alpha,20-epoxy-ent-kaur-16-ene|maoyecrystal F
(rel 5S,6R,8R,9R,10S,13S)-6-acetoxy-9,13-epoxy-15-methoxy-labdan-16,15-olide
2-hydroxy-4-methoxy-5,6-O-(4-isopropyl-1beta-methyl-cyclohexane-1-O,5-yl)dihydrochalcone
4-O-acetyl-7alpha-hydroperoxy-11,13-dehydro-7,11-dihydrocuauthemone 3-O-angelate
(4RS,4aSR,5RS,6SR,8aSR,9aSR)-6-(acetyloxy)-2,4,4a,5,6,7,8,8a,9,9a-decahydro-8a-hydroxy-3,4a,5-trimethyl-2-oxonaphtho[2,3-b]furan-4-yl 2-methylbutanoate|3beta-(acetyloxy)-6beta-(2-methylbutanoyloxy)-10beta-hydroxyeremophil-7(11)-en-12,8alpha-olide
(5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-16,15-olide|(rel 5S,6R,8R,9R,10S)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-16,15-olide
7alpha,11beta,12alpha,14beta-tetrahydroxy-20-acetoxy-ent-kaur-16-en-15-one|isolushinin G
12-deoxyisodomedin|1alpha,7alpha,12alpha,14beta-tetrahydroxy-3-beta-acetoxy-ent-kaur-16-en-15-one|pharicunin G
epinodosinol-neoangustifolin 1:1 complex|Neoangustifolin
4-O-acetyl-7beta,11-epoxycuauthemone 3-O-epoxyangelate
C22H32O7_Butanoic acid, 3-methyl-, (3alpha,8alpha,12xi)-15-(acetyloxy)-12,13-epoxy-3-hydroxytrichothec-9-en-8-yl ester
C22H32O7_Phenanthro[3,2-b]furan-9(1H)-one, 5-(acetyloxy)-2,3,4,4a,5,6,6a,7,10a,11,11a,11b-dodecahydro-6,10a-dihydroxy-4-(hydroxymethyl)-4,7,11b-trimethyl
C23H36O6_1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta-dihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (betaR,deltaR,1S,2S,8S,8aR)
[6,10a-dihydroxy-4-(hydroxymethyl)-4,7,11b-trimethyl-9-oxo-1,2,3,4a,5,6,6a,7,11,11a-decahydronaphtho[2,1-f][1]benzofuran-5-yl] acetate
2-hydroxy-4-methoxy-3,5-bis(3-methylbut-2-enyl)-6-(2-phenylethyl)benzoic acid
(3R,5R)-7-[(1S,2S,8S,8aR)-2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[(1S,2S,8S,8aR)-2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid_major
Pro Pro Pro Val
Pro Pro Val Pro
Pro Val Pro Pro
Val Pro Pro Pro
cis-Methylbixin
Anhydrocinnzeylanine
Isomethylbixin
Heterophylol
6,10a-Dihydroxy-4-(hydroxymethyl)-4,7,11b-trimethyl-9-oxo-1,2,3,4,4a,5,6,6a,7,9,10a,11,11a,11b-tetradecahydrophenanthro[3,2-b]furan-5-yl acetate
(3R,5R)-3,5-Dihydroxy-7-{(1S,2S,8S,8aR)-2-methyl-8-[(2-methylbutanoyl)oxy]-1,2,6,7,8,8a-hexahydro-1-naphthalenyl}heptanoic acid
4-tert-butylphenol,formaldehyde,4-[2-(4-hydroxyphenyl)propyl]phenol
2,2-AZOBIS[2-METHYL-N-[1,1-BIS(HYDROXYMETHYL)-2-HYDROXYETHYL]PROPIONAMIDE]
Lofentanil
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
1H-Pyrazole-5-carboxamide, 3-(3-(dimethylamino)propoxy)-N-(4-methoxyphenyl)-1-(phenylmethyl)-
2-[4-(Dimethylamino)phenyl]azobenzoic acid [2-(1-azepanyl)-2-oxoethyl] ester
Carbobenzyloxy-(L)-leucinyl-(L)leucinyl methoxymethylketone
3,5-Dihydroxy-7-[2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid
[(2R)-2-hydroxy-3-phosphonooxypropyl] (E)-hexadec-9-enoate
1-[2-Imino-3-[2-(1-piperidinyl)ethyl]-1-benzimidazolyl]-3-(3-methylphenoxy)-2-propanol
[(1S,2S,5R,7R,8R,9S,10S,11R,15S,18R)-7,9,10,18-tetrahydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.15,8.01,11.02,8]octadecan-15-yl] acetate
1-[3-(dimethylamino)propyl]-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-phenylurea
1-[2-(dimethylamino)ethyl]-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(phenylmethyl)urea
N-[3-(2,6-dimethyl-1-piperidinyl)propyl]-1,5-dimethyl-4-oxo-2-pyrrolo[3,2-c]quinolinecarboxamide
2-oxo-3-[(8S)-epoxy-(2E,6E)-farnesyl]-6-(pyridin-3-yl)-2H-pyran-4-olate
(1S,9R,10R,11R)-12-(cyclopropylmethyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
cyclopentyl-[(2R,3R)-6-[(4-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]methanone
(2R,3R)-2-(hydroxymethyl)-6-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide
1-[(2S,3S)-1-(cyclopropylmethyl)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone
(2S,3S)-2-(hydroxymethyl)-6-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
(1R,9S,10S,11S)-12-(cyclopropylmethyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(8S,9R,10R)-9-[4-(1-cyclopentenyl)phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
1-[(2S,3S)-1-[(3-fluorophenyl)methyl]-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]propan-1-one
1-[(2R,3R)-1-(cyclopropylmethyl)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone
1-[(2S,3R)-1-(cyclopropylmethyl)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-1-propanone
(2S,3R)-2-(hydroxymethyl)-6-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide
ethyl 2,7,7-trimethyl-4-(1-methyl-3,4-dihydro-2H-quinolin-6-yl)-5-oxo-3,4,6,8-tetrahydroquinoline-3-carboxylate
N-(6-aminohexyl)-2-(3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)acetamide
[(E)-2-(butanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(propanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-acetamido-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(pentanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
lofentanyl
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
1-Palmitoylglycerol 3-phosphate(2-)
An organophosphate oxoanion arising from deprotonation of the phosphate OH groups of 1-palmitoylglycerol 3-phosphate; major species at pH 7.3.
1-palmitoleoyl-sn-glycerol 3-phosphate
A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as palmitoleoyl.
1-Palmitoyl-sn-glycerol 3-phosphate(2-)
Dianion of 1-palmitoyl-sn-glycerol 3-phosphate arising from deprotonation of both OH groups of the phosphate.
BisMePA(14:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
CYM51010
CYM51010 is a biased ligand of μ-opioid receptor – δ-opioid receptor heterodimers with an EC50 of 403 nM. CYM51010 exhibits anti-nociceptive activity similar to morphine but with a decreased levels of tolerance development and withdrawal symptoms[1].
8-(acetyloxy)-3',3',4a,8-tetramethyl-3-oxo-hexahydrospiro[naphthalene-2,2'-oxiran]-7-yl 2,3-dimethyloxirane-2-carboxylate
(1r,1's,2r,6s,6's,7's,9's,11'r)-7',11'-dihydroxy-2-(hydroxymethyl)-3,3-dimethyl-10'-methylidene-2'-oxo-3'-oxaspiro[cyclohexane-1,5'-tricyclo[7.2.1.0¹,⁶]dodecan]-6-yl acetate
methyl (1r,2s,5e)-2-[(2e,5s)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate
(1e,5e)-1-[6-(2,3-dihydroxy-3-methylbutyl)-3-hydroxy-2-(hydroxymethyl)phenyl]undeca-1,5-diene-3,4-diol
4-hexyl-9,10,15-trihydroxy-5,11,19-trioxapentacyclo[8.7.1.1³,⁶.0⁶,¹⁸.0¹²,¹⁷]nonadec-12(17)-en-16-one
(1r,2s,4r,4ar,5s,6r,8s,8as)-5-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,8-dihydroxy-5,6,8a-trimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl acetate
1-{2,6-dihydroxy-3-[(1s,6s)-6-isopropyl-3-methylcyclohex-2-en-1-yl]-4-methoxyphenyl}-3-phenylpropan-1-one
3-[(2e)-7,11-dihydroxy-3,7,11-trimethyldodec-2-en-1-yl]-2,4-dihydroxy-6-methylbenzoic acid
(1r,2s,4ar,5s,6r,8s,8ar)-5-[(2r)-2-(furan-3-yl)-2-hydroxyethyl]-2-hydroxy-8a-(hydroxymethyl)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8-yl acetate
(3r)-n-{2-[(7ar)-3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene]acetyl}-3-hydroxytetradecanimidic acid
5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate
(1r,2r,4r,6s,8s,9r,10s,13r,14r,16r)-2,8,16-trihydroxy-5,5,9,14-tetramethyl-12,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-6-yl acetate
methyl 2-[(2r,3r,4ar,7s,8as)-3-(acetyloxy)-8a-hydroxy-4a-methyl-8-methylidene-7-[(2-methylpropanoyl)oxy]-hexahydro-1h-naphthalen-2-yl]prop-2-enoate
(4s,4ar,5s,6r,8ar,9ar)-6-(acetyloxy)-8a-hydroxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-4-yl (2r)-2-methylbutanoate
6-(acetyloxy)-8a-hydroxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-4-yl 2-methylbutanoate
14,16-dihydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-ene-3,11-dione
1-(2-hydroxy-6-{[(1s,4r)-1-isopropyl-4-methylcyclohex-2-en-1-yl]oxy}-4-methoxyphenyl)-3-phenylpropan-1-one
4-hydroxy-4-[2-(2-methoxy-5-oxo-2h-furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate
(1r,3s,4r,7s,8r,12r)-3-hydroxy-4,8,12-trimethyl-15-methylidene-11,14-dioxo-13,18-dioxatricyclo[10.3.2.1⁴,⁸]octadecan-7-yl acetate
1-(2-hydroxy-6-{[(1r)-1-isopropyl-4-methylcyclohex-3-en-1-yl]oxy}-4-methoxyphenyl)-3-phenylpropan-1-one
4-[(2s,2ar,7as)-4,6-dimethoxy-1,1-dimethyl-3-(3-methylbut-2-en-1-yl)-2h,2ah,7h,7ah-cyclobuta[a]inden-2-yl]benzene-1,2-diol
methyl 2-[(1r,3s,4e,7e,11s,12r)-11-(acetyloxy)-3,12-dihydroxy-4,8,12-trimethylcyclotetradeca-4,7-dien-1-yl]prop-2-enoate
1,7-dimethyl (2e,6e)-2-[(3r)-3,4-dihydroxy-4-methylpentyl]-6-[3-(furan-3-yl)propylidene]hept-2-enedioate
6-[3-(4-hydroxy-2-methoxyphenyl)propyl]-2,2-dimethyl-5-(3-methylbut-2-en-1-yl)chromen-8-ol
(1s,2s,4ar,8ar)-1-(acetyloxy)-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate
6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one
8,9,13-trihydroxy-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-4-yl acetate
1,20-dimethyl (6e,8e,10e,12e,14e,16e,18e)-4,8,13,17-tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioate
(1's,2r,2's,4'r,5's,6'r,11's)-5'-[(2r,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-11'-hydroxy-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-2'-yl acetate
(1's,2r,2'r,4'r,5'r,6's,8's,11's)-5'-[(2r,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-11'-hydroxy-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-2'-yl acetate
3-hydroxy-n-(2-{3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene}acetyl)tetradecanimidic acid
(1s,2r,2'r,3s,4's,4as,5's,8ar)-2',3-dihydroxy-5'-[(2r)-2-hydroxybut-3-en-2-yl]-2,4a,5-trimethyl-7-oxo-3,4,8,8a-tetrahydro-2h-spiro[naphthalene-1,3'-oxolan]-4'-yl acetate
1-[2,3-bis(acetyloxy)-6-oxocyclohex-1-en-1-yl]dec-2-en-4-yl acetate
(1s,4s,5s,6r)-6-(acetyloxy)-2-(hydroxymethyl)-5-isopropyl-4-{[(2e)-2-methylbut-2-enoyl]oxy}cyclohex-2-en-1-yl (2e)-2-methylbut-2-enoate
10β-acetoxy-2α,5α,7β,9α-tetrahydroxytaxa-4(20),11-dien-13-one
{"Ingredient_id": "HBIN000063","Ingredient_name": "10\u03b2-acetoxy-2\u03b1,5\u03b1,7\u03b2,9\u03b1-tetrahydroxytaxa-4(20),11-dien-13-one","Alias": "NA","Ingredient_formula": "C22H32O7","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C(=C)C3C(C(C2(C)C)CC1=O)O)O)O)C)O)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "288","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-angeloyloxy-6β-ethoxy-8β,10β-dihydroxy-eremophilenolide
{"Ingredient_id": "HBIN008183","Ingredient_name": "3\u03b2-angeloyloxy-6\u03b2-ethoxy-8\u03b2,10\u03b2-dihydroxy-eremophilenolide","Alias": "NA","Ingredient_formula": "C22H32O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1222","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
asebotoxin ii
{"Ingredient_id": "HBIN017047","Ingredient_name": "asebotoxin ii","Alias": "NA","Ingredient_formula": "C23H36O6","Ingredient_Smile": "CCC(=O)OC1C2CCC3C1(CC(C4(C(C3=C)CC(C4(C)C)O)O)O)CC2(C)O","Ingredient_weight": "408.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1849","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "135876151","DrugBank_id": "NA"}